Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: The ODYSSEY ESCAPE trial - Moriarty, P M; Parhofer, K G; Babirak, S P (Eur Heart J, 2016)
et al.